Emma Jensen
Overview
Explore the profile of Emma Jensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dutton M, Can A, Beaudequin D, Jensen E, Jones M, Gallay C, et al.
J Affect Disord
. 2022 Jan;
300:410-417.
PMID: 35016117
Background: Stress is prevalent in people experiencing suicidality and is a major contributor to the development of mental disorders. Evidence suggests ketamine shows capacity to reverse stress-induced brain changes. Though...
2.
Beaudequin D, Can A, Jones M, Yang C, Scherman J, Dutton M, et al.
Psychiatry Res
. 2021 Sep;
305:114212.
PMID: 34563973
Recovery of functioning is integral to successful treatment outcomes in depressive illness. Optimal antidepressant treatment results in both symptomatic remission and functional recovery. Oral ketamine rapidly reduces suicidality and depression;...
3.
Gallay C, Forsyth G, Can A, Dutton M, Jamieson D, Jensen E, et al.
Psychiatry Res Neuroimaging
. 2021 Aug;
317:111369.
PMID: 34461430
Chronic suicidality has been associated with neuronal atrophy in cortico-striato-limbic regions and is thought to be mediated via a glutamatergic imbalance. Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has been posited...
4.
Can A, Hermens D, Dutton M, Gallay C, Jensen E, Jones M, et al.
Transl Psychiatry
. 2021 Feb;
11(1):101.
PMID: 33542187
Recently, low-dose ketamine has been proposed as a rapid-acting treatment option for suicidality. The majority of studies to date have utilised intravenous (IV) ketamine, however, this route of administration has...